Actively Recruiting
Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
Led by Hikma Pharmaceuticals LLC · Updated on 2025-03-26
240
Participants Needed
4
Research Sites
223 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
CONDITIONS
Official Title
Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Newly diagnosed with Philadelphia chromosome-positive Chronic Myeloid Leukemia in the chronic phase
- Diagnosis confirmed within 3 months before enrollment and not yet treated
- Liver aminotransferases and serum bilirubin levels at or below 2 times the upper normal limit
- Serum creatinine at or below 1.5 times the upper normal limit
- Provided written informed consent
You will not qualify if you...
- Accelerated phase Chronic Myeloid Leukemia at enrollment, except if with other cytogenetic abnormalities at diagnosis
- Blast phase Chronic Myeloid Leukemia at enrollment
- Any contraindications to the study drug according to its approved product information
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
National Cancer Institute (NCI)
Cairo, Egypt, 11796
Actively Recruiting
2
Ain Shams University Hospital
Cairo, Egypt
Not Yet Recruiting
3
Nasser Institute
Cairo, Egypt
Actively Recruiting
4
Tanta Oncology Center
Tanta, Egypt
Not Yet Recruiting
Research Team
R
Ruba A Jaber
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here